Results of a phase II, open‐label, non‐comparative study of intralesional PV‐10 followed by radiotherapy for the treatment of in‐transit or metastatic melanoma

BACKGROUND: In‐transit and recurrent dermal or subcutaneous melanoma metastases represent a significant burden of advanced disease. Intralesional Rose Bengal can elicit tumor selective ablation and a T‐cell mediated abscopal effect in untreated lesions. A subset of patients in a phase II trial setti...

Descripción completa

Detalles Bibliográficos
Autores principales: Foote, Matthew, Read, Tavis, Thomas, Janine, Wagels, Michael, Burmeister, Bryan, Smithers, B. Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221132/
https://www.ncbi.nlm.nih.gov/pubmed/28230241
http://dx.doi.org/10.1002/jso.24580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221132/
https://www.ncbi.nlm.nih.gov/pubmed/28230241
http://dx.doi.org/10.1002/jso.24580

Ejemplares similares